Related references
Note: Only part of the references are listed.Structural Basis for α-Helix Mimicry and Inhibition of Protein-Protein Interactions with Oligourea Foldamers
Leonie Cussol et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2021)
KPC-2 β-lactamase enables carbapenem antibiotic resistance through fast deacylation of the covalent intermediate
Shrenik C. Mehta et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2021)
Mapping Protein-Protein Interaction Interface Peptides with Jun-Fos Assisted Phage Display and Deep Sequencing
Wanzhi Huang et al.
ACS SYNTHETIC BIOLOGY (2020)
Recent advances in the development of protein-protein interactions modulators: mechanisms and clinical trials
Haiying Lu et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2020)
Macrocyclic Peptides as Drug Candidates: Recent Progress and Remaining Challenges
Alexander A. Vinogradov et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2019)
Multicomponent Reaction Toolbox for Peptide Macrocyclization and Stapling
Leslie Reguera et al.
CHEMICAL REVIEWS (2019)
High-throughput identification of dominant negative polypeptides in yeast
Michael W. Dorrity et al.
NATURE METHODS (2019)
Structures and disulfide cross-linking of de novo designed therapeutic mini-proteins
Daniel-Adriano Silva et al.
FEBS JOURNAL (2018)
Constrained peptides' time to shine?
Chris Morrison
NATURE REVIEWS DRUG DISCOVERY (2018)
Structural and Mechanistic Basis for Extended-Spectrum Drug-Resistance Mutations in Altering the Specificity of TEM, CTX-M, and KPC β-lactamases
Timothy Palzkill
FRONTIERS IN MOLECULAR BIOSCIENCES (2018)
PROTEIN MAPS CHART THE CAUSES OF DISEASE
Marissa Fessenden
NATURE (2017)
Massively parallel de novo protein design for targeted therapeutics
Aaron Chevalier et al.
NATURE (2017)
Exploring sequence space: harnessing chemical and biological diversity towards new peptide leads
Richard Obexer et al.
CURRENT OPINION IN CHEMICAL BIOLOGY (2017)
BLIP-II Employs Differential Hotspot Residues To Bind Structurally Similar Staphylococcus aureus PBP2a and Class A β-Lactamases
Carolyn J. Adamski et al.
BIOCHEMISTRY (2017)
De Novo Evolutionary Emergence of a Symmetrical Protein Is Shaped by Folding Constraints
Robert G. Smock et al.
CELL (2016)
Analysis of Loops that Mediate Protein-Protein Interactions and Translation into Submicromolar Inhibitors
Timothy R. Siegert et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2016)
Targeting diverse protein-protein interaction interfaces with α/β-peptides derived from the Z-domain scaffold
James W. Checco et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Lessons from Hot Spot Analysis for Fragment-Basec Drug Discovery
David R. Hall et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2015)
Small-Molecule Inhibitors of Protein-Protein Interactions: Progressing toward the Reality
Michelle R. Arkin et al.
CHEMISTRY & BIOLOGY (2014)
Hydrocarbon-Stapled Peptides: Principles, Practice, and Progress
Loren D. Walensky et al.
JOURNAL OF MEDICINAL CHEMISTRY (2014)
Large-scale de novo DNA synthesis: technologies and applications
Sriram Kosuri et al.
NATURE METHODS (2014)
Identification of human single-chain antibodies with broad reactivity for noroviruses
Wanzhi Huang et al.
PROTEIN ENGINEERING DESIGN & SELECTION (2014)
Role of β-lactamase residues in a common interface for binding the structurally unrelated inhibitory proteins BLIP and BLIP-II
Bartlomiej G. Fryszczyn et al.
PROTEIN SCIENCE (2014)
Getting in Shape: Controlling Peptide Bioactivity and Bioavailability Using Conformational Constraints
Jonathan E. Bock et al.
ACS CHEMICAL BIOLOGY (2013)
Pharmacological Inactivation of Skp2 SCF Ubiquitin Ligase Restricts Cancer Stem Cell Traits and Cancer Progression
Chia-Hsin Chan et al.
CELL (2013)
Identification of the β-Lactamase Inhibitor Protein-II (BLIP-II) Interface Residues Essential for Binding Affinity and Specificity for Class A β-Lactamases
Nicholas G. Brown et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
Stapled α-helical peptide drug development: A potent dual inhibitor of MDM2 and MDMX for p53-dependent cancer therapy
Yong S. Chang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Analysis of the Binding Forces Driving the Tight Interactions between β-Lactamase Inhibitory Protein-II (BLIP-II) and Class A β-Lactamases
Nicholas G. Brown et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Systematic Analysis of Helical Protein Interfaces Reveals Targets for Synthetic Inhibitors
Andrea L. Jochim et al.
ACS CHEMICAL BIOLOGY (2010)
Interactome under construction
Laura Bonetta
NATURE (2010)
Identification and characterization of β-lactamase inhibitor protein-II (BLIP-II) interactions with β-lactamases using phage display
N. G. Brown et al.
PROTEIN ENGINEERING DESIGN & SELECTION (2010)
Structural and Biochemical Characterization of the Interaction between KPC-2 β-Lactamase and β-Lactamase Inhibitor Protein
Melinda S. Hanes et al.
BIOCHEMISTRY (2009)
Three Decades of the Class A beta-Lactamase Acyl-Enzyme
Jed F. Fisher et al.
CURRENT PROTEIN & PEPTIDE SCIENCE (2009)
Phage-encoded combinatorial chemical libraries based on bicyclic peptides
Christian Heinis et al.
NATURE CHEMICAL BIOLOGY (2009)
Reaching for high-hanging fruit in drug discovery at protein-protein interfaces
James A. Wells et al.
NATURE (2007)
Crystal structure of KPC-2:: Insights into carbapenemase activity in class a β-lactamases
Wei Ke et al.
BIOCHEMISTRY (2007)
Biochemical characterisation of the CTX-M-14 β-lactamase
Yoshikazu Ishii et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2007)
An inhibitor of Bcl-2 family proteins induces regression of solid tumours
T Oltersdorf et al.
NATURE (2005)
Bacterial resistance to β-lactam antibiotics:: Compelling opportunism, compelling opportunity
JF Fisher et al.
CHEMICAL REVIEWS (2005)
Small-molecule inhibitors of protein-protein interactions: Progressing towards the dream
MR Arkin et al.
NATURE REVIEWS DRUG DISCOVERY (2004)
Helical β-peptide inhibitors of the p53-hDM2 interaction
JA Kritzer et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2004)
Dissecting the protein-protein interface between β-lactamase inhibitory protein and class A β-lactamases
Z Zhang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Determinants of binding affinity and specificity for the interaction of TEM-1 and SME-1 β-lactamase with β-lactamase inhibitory protein
Z Zhang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Crystal structure and kinetic analysis of β-lactamase inhibitor protein-II in complex with TEM-1 β-lactamase
D Lim et al.
NATURE STRUCTURAL BIOLOGY (2001)
ASEdb: a database of alanine mutations and their effects on the free energy of binding in protein interactions
KS Thorn et al.
BIOINFORMATICS (2001)